Rates of necrotising enterocolitis (NEC) may be reduced by almost 50% by feeding human donor milk, as opposed to formula, to preterm infants whose own mothers do not provide breast milk. 1 Based on aggregated results of randomised controlled trials (RCT), feeding 30 preterm infants donor milk instead of formula may prevent one case of NEC. Claims for other beneficial effects of donor milk failed the RCT test, while the issue is subjected to several large ongoing trials.Medical interventions come at a cost, and estimating these costs is important for policy makers and healthcare providers. Josefine Fengler et al 2 successfully enlisted the help of the financial department of a university hospital (admitting slightly <50 very low birth weight infants per year) to calculate the costs of feeding preterm infants their own mother's milk, donor milk or formula. Preterm infants whose own mothers did not provide breast milk received donor milk for an average of 19 days (until being switched to formula at 32 weeks postmenstrual age). This incurred costs of €272, as opposed to €126 if the baby had received mother's own milk, or €34 if the baby had received formula. Thus, the additional costs of feeding donor milk were well below those of a single vial of surfactant. With a number needed to feed of 30, preventing one case of NEC would require €7140 for money spent on donor milk.Cost analyses may also serve as a starting point to identify unwarranted expenditures. More than a quarter of the marginal costs of donor milk resulted from microbiological examinations, triggered by efforts to feed unpasteurised milk. There is no consensus for recommendations for the microbiological testing of donor milk. 3 Risks and benefits of feeding unpasteurised human donor milk are unknown, as almost all (11/12) randomised controlled trials comparing donor milk with formula employed pasteurisation. 1 Pasteurisation of donor milk, as advocated by the European Milk Bank Association, 3 not only blocks viral and bacterial pathogen transmissions but apparently also saves money. Scrutinising operational sequences for procedures without proven added value is becoming an increasingly important task to reduce their financial burden. Furthermore, the authors point out that the costs per unit of donor milk decline with the number of units being processed. 2 Thus, human milk banks benefit from perinatal regionalisation. Focusing the care of very preterm infants to a small number of hospitals engenders superior results 4 and allows for the daily workload to be organised in a more cost-efficient fashion. Under certain conditions, economic considerations may be friends rather than foes of our endeavours to achieve the best outcome possible for very preterm infants.